by American College of Physicians Credit: Pixabay/CC0 Public Domain A propensity score-matched cohort study of patients treated for chronic obstructive pulmonary disease (COPD) in routine practice found that the use of generic and brand-name fluticasone–salmeterol was associated with similar outcomes. The findings are published in Annals of Internal Medicine. In 2019, the U.S. Food and Drug Administration (FDA) approved...
